Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patients
- PMID: 33506088
- PMCID: PMC7798301
- DOI: 10.1515/iss-2020-0010
Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patients
Abstract
Objectives: The updated 8th edition of the tumor, node, metastases (TNM) classification system for non-small cell lung cancer (NSCLC) attempts to improve on the previous 7th edition in predicting outcomes and guiding management decisions. This study sought to determine whether the 8th edition was more accurate in predicting long-term survival in a European population of surgically treated NSCLC patients.
Methods: We scanned the archives of the Heckeshorn Lung Clinic for patients with preoperative clinical stages of IIIA or lower (based on the 7th edition), who received surgery for NSCLC between 2009 and 2014. We used pathologists' reports and data on tumor size and location to reassign tumor stages according to the 8th edition. We then analyzed stage specific survival and compared the accuracy of the two systems in predicting long-term survival. We excluded patients with neoadjuvant treatment, incomplete follow-up data, tumor histologies other than NSCLC, or death within 30 days of surgery.
Results: The final analysis included 1,013 patients. Overall five-year survival was 47.3%. The median overall survival (OS) was 63 months (range 1-222), and the median disease-free survival (DFS) was 50 months (0-122). The median follow-up time for non-censored patients was 84 months (range 60-122).
Conclusions: We found significant survival differences between the newly defined stages 1A1, 1A2 and 1A3 (previously 1A). We also found that the 8th edition of TMN classification was a significantly better predictor of long-term survival, compared to the 7th edition.
Keywords: NSCLC; TNM; lung cancer; prognosis; staging; thoracic surgery; validation.
© 2020 Samantha Taber et al., published by De Gruyter, Berlin/Boston.
Conflict of interest statement
Competing interests: Authors state no conflict of interest.
Figures


Similar articles
-
Validation of the 8th edition of the TNM staging system in 3,950 patients with surgically resected non-small cell lung cancer.J Thorac Dis. 2019 Jul;11(7):2955-2964. doi: 10.21037/jtd.2019.07.43. J Thorac Dis. 2019. PMID: 31463125 Free PMC article.
-
Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis.J Thorac Dis. 2017 Dec;9(12):5335-5344. doi: 10.21037/jtd.2017.12.101. J Thorac Dis. 2017. PMID: 29312743 Free PMC article.
-
A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.Oral Oncol. 2018 Dec;87:158-164. doi: 10.1016/j.oraloncology.2018.11.003. Epub 2018 Nov 9. Oral Oncol. 2018. PMID: 30527232
-
Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.Oncologist. 2021 Mar;26(3):e445-e453. doi: 10.1002/onco.13535. Epub 2020 Oct 3. Oncologist. 2021. PMID: 32969134 Free PMC article.
-
Superiority of the 8th edition of the TNM staging system for predicting overall survival in gastric cancer: Comparative analysis of the 7th and 8th editions in a monoinstitutional cohort.Mol Clin Oncol. 2018 Oct;9(4):423-431. doi: 10.3892/mco.2018.1683. Epub 2018 Jul 26. Mol Clin Oncol. 2018. PMID: 30214731 Free PMC article.
Cited by
-
Silencing of circRPPH1 Inhibits the Progression of Non-Small-Cell Lung Cancer Through miR-326/ERBB4 Signal Axis.Biochem Genet. 2025 Jun;63(3):2393-2408. doi: 10.1007/s10528-024-10824-3. Epub 2024 May 22. Biochem Genet. 2025. PMID: 38776052
-
Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort study.BJS Open. 2024 Mar 1;8(2):zrae008. doi: 10.1093/bjsopen/zrae008. BJS Open. 2024. PMID: 38513281 Free PMC article.
-
Non-metastatic hip fractures surgery in patients with active cancer: benefit and risk.Int Orthop. 2024 Apr;48(4):1089-1096. doi: 10.1007/s00264-024-06111-w. Epub 2024 Feb 9. Int Orthop. 2024. PMID: 38332113
-
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.Cancer Immunol Immunother. 2023 Jul;72(7):2205-2215. doi: 10.1007/s00262-023-03393-8. Epub 2023 Mar 2. Cancer Immunol Immunother. 2023. PMID: 36862151 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources